Reducing the Risk of Endometrial Cancer in Patients Receiving Selective Estrogen Receptor Modulator (SERM) Therapy
None
Saved in:
| Main Author: | Vogel, Victor G. |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
IntechOpen
2012
|
| Subjects: | |
| Online Access: | https://www.intechopen.com/chapters/29773 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Endometrial expression of e-cadherin in relation to estrogen-progesterone receptor characteristics of the endometrium
by: S. S. Aganezov, et al.
Published: (2020-07-01) -
Role of steroid hormones, estrogen receptors and metabolites in the development of endometrial hyperplasia and carcinoma
by: A. L. Chernyshova, et al.
Published: (2012-12-01) -
Roles and Mechanisms of Estrogen and Estrogen Receptors in Breast Cancer Resistant to Chemotherapy
by: Fan, Weimin, et al.
Published: (2011) -
NEOADJUVANT ENDOCRINE THERAPY FOR PATIENTS WITH ESTROGEN-RECEPTOR-POSITIVE BREAST CANCER
by: V. F. Semiglazov, et al.
Published: (2018-07-01) -
Endometrial expression of leukemia inhibitory factor in women with different estrogen/progesterone receptor status of the endometrium
by: S. S. Aganezov, et al.
Published: (2019-07-01)


